Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did they ever even have any products in stock? We know Nupelo never existed and is just a website with an image of a product. They have frauded investors with years of BS and no results while only selling shares and no products. I wonder what the next excuses will be from IR will be, if they ever even communicate with anyone.
How the hell can we run out of product. UNBELIEVABLE. !!!!!
Bring on the lawsuits. This is absolutely criminal what Otiko has done here.
Vitastem Ultra 55ML Spray
Product is out of stock and orders are not being accepted until stock is replenished
Regular price 149.95
Tax included.
Vitastem Ultra is a Powerful Super-Healing Topical Antibiotic for Treating Infections, Wounds, Diabetic Foot Ulcers, Bed & Pressure Sores, Burns, Skin Rash, Acne and many other skin conditions.
Sold Out Items - Any orders placed will be shipped when inventory is restocked.
Items should be back in stock by August 2024
Vitastem was just bait & that's even gone
If they do, it'll be trading in trips and it will likely never recover. No one will stick around or bother touching this stock in the future. Otiko would kill the company entirely at that point. They need sales and having the strongest topical antibiotic in the world (in their words) should be selling everywhere, so why isn't it?
No PRs or social media updates in nearly 6 months now and IR won't answer anyones questions. Stinks more and more like a huge scam as each day passes.
I wonder when they will raise the AS again 😉
Not many posts lately. I guess there's nothing to say anymore. We're in free fall waiting on something, anything from Nigerian counterpart.
Can someone reach the guy who's supposed to be in charge of the company. Tell him the company is on fire and he needs to put it out before there is nothing left.
Can someone reach the guy with the Bird logo? He might know more than many around here in which cave out Nigerian Vampire is at this time
I might start nibbling when the 2s come
Fdc4 At least you can see the big picture
That is a bad call if someone made complaints on this. Worse case scenario Otiko is shipped back to private with a small fine to pay to the SEC and you and the rest of the suckers, including me, in La La land, but with our pride intact by sending OTIKO out of the OTCM. Smh, fuck pride, I am going to lose more by sending this to Expert P. I have seen scams like this going up and down, we have to be patient
Looks like someone lost thier patience and thier cash
Don't be so sure about that. Complaints are being filed and you should assume lawsuits are coming.
hold tight ya may be able to buy .0011 to 0015 .. sad to say i never thought we would be back there but sure is looking that way ..🥵☹️
I will buy those 32’s!! If they come back
3.5 milly dumped at .0032
Last one to leave, shut the lights
VDRM ViaDerma Inc
0.0033 -0.00202 (-37.97%)
I guess this is progress? Idiots! Almost 5 million shares traded. Everyone bailing.
Having a tough red week? 😨
Nothing much happening here probably till September at the earliest then I think that the push is on we will see
Thanks for the feedback… If you are accurate on IR Intel, their silence means they are making amendments for their financial mistakes. It takes time. Anyways, about the adding/investing part, ARE YOU NUTS? HELL TO THE NOO…. I am waiting for $10K to be cleared in my account but I will be darned if I put a penny more of such in VDRM. Heck to the Noo… That money has name all over it:
$SMCE
They must be speaking of the progress on the Vitastem suppositories. Bad news for Sloppy and DB as the attempt to make them big enough for folks like them has been terminated and they will come to market in a standard size. If anyone believes this suppository nonsense, then you will probably believe the "active" and "still making progress" bullcrap. Just accept this for the scam that it is. For those who were smart enough to buy low and sell on the runs that came from all the BS press releases, congrats. But cut the crap that they are still active and making progress. LMMFAO!!!!
MV post the number & his comments please
I Just spoke to IR. Still active. Still making progress. This could be a very good opportunity to buy in. IN MY OPINION.
Nobody will make a complaint. The Doc, is a bitch a$$ Con but he is our bitch a$$ Con. You snitch him out, you snitch on ourselves as well. We get dumped homie, by the blue bitches mate
Hahahahahahaha, that sounded gettho enough 😂
I hope the little birdie doesn't say our goose is cooked.
Hummingbird2 —— Helpppppp what is going on with the Dr. are we still in business? Does the little birdie know something that we don’t …
Not me. I was ok sending a letter to VDRM's securities counsel but not to the SEC. To me, it's one of those be careful what you wish for scenarios. We may win the battle but lose the war if the stock becomes untradeable. Honestly though I don't know much about the complaint process as to whether they will jump on it and take it seriously or throw it in a pile with the rest of the penny scam complaints.
Has anyone made out a complaint yet?
What happened to our 3 new employee's we just hired did we lay them off already?
They used to communicate with shareholders. Now they don't and have not in several months. Reading through many of the posts on ihub it seems like no one has been able to get any information from the useless IR guy or Otiko either. Everything was looking good in 2023 and thought we were turning a corner with the company but it seems like many more Otiko lies again.
You were cheerleading this company not too long ago. You misplaced your rose colored glasses apparently. Now you are posting like you just discovered America…..but I’ve been livin here for years
Maybe their business model is that VDRM will not actually carry inventory. I had noted that the Company has not reported any inventory on the balance sheet for about 3 years. Something that GC pointed out ...the fact that they created a distributor (Viaderma Distribution) may be such that the distributor is the entity that is supposed to actually carry the inventory. Or maybe the Company intends to sell direct from the manufacturer in which case the Company never takes title to the inventory. Maybe this all would be relevant with a real company; coming from Otiko, it's likely all fraudulent bullsh*t.
In fairness, Viaderma is at fault with all of this. NOT ONE of their PRs or social media updates have proved to be the least bit valid in the past several years.
Vitastem shipments overseas in March? It's a big ass nothing burger. Same with Nupelo, VA, HMO, Dubai deals, OTC up listing. And now for weeks there are no products available for sale on the website. No inventory? WTF is going on here. Especially with their misleading financial statements with so many discrepancies that they won't even answer about.
Otiko and Rich Inza are behind all of this. They've gone completely silent for months and are hiding from shareholders. It sure seems very fraudulent what they're doing or not doing for the company's shareholders and Otiko needs to be held accountable.
Here is a SEC complaint form https://help.sec.gov/s/investor-complaint
And you would think with 5000 posts on VDRM He would of been right at least once. But that never happened😂
Looks like a VERY sloppy pumper was wrong here the ENTIRE time 😢 😂
They have Zero product to sell. No miracles here. So sorry
Safe to say Otiko is a con man. Still not one response from him or useless rich from IR either in many months now who probably quit working with them for all we know.
Talking with litigation attorneys this week. Enough is enough.
Congrats Otiko. Trading in .004s, a new low. You must be so proud.
Nope, been around quite a while though! This one looks to be toes up, do you disagree? Reading through recent posts and attempts to communicate with doc and IR, seems there isn’t much to be said anyway..
Hey trani3, you don't say much do you?
Followers
|
619
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
74600
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |